ClinicalTrials.Veeva

Menu

Prevalence of Problematic Use of Social Media (PURPLE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Not yet enrolling

Conditions

Addiction
Social Networks

Treatments

Other: Self-administered survey

Study type

Observational

Funder types

Other

Identifiers

NCT06798480
2024-A02539-38 (Other Identifier)
69HCL24_0042

Details and patient eligibility

About

In 2023, French individuals spend an average of two hours per day on social media platforms (SM), primarily Facebook, TikTok, X, YouTube, Instagram, and Snapchat. While social media offers undeniable benefits, it also raises concerns about its impact on mental health and well-being. These impacts remain poorly understood, partly due to the diversity of social media uses and motivations, which do not have uniform effects on health. For instance, studies have shown that "active" use of social media (e.g., content creation) is associated with higher well-being, whereas "passive" use (e.g., content scrolling) is linked to lower well-being.

This challenge in understanding the variety of social media uses and their consequences has direct clinical implications. Clinicians working in pediatrics, child psychiatry, and addiction medicine are increasingly confronted with patients struggling to manage their social media use. However, they lack clear diagnostic criteria to differentiate between normal and problematic use, as well as specific tools tailored to address potential disorders.

Moreover, in France, there is no existing estimate of the proportion of the general population affected by problematic social media use.

This study aims to establish the prevalence of problematic use of social media in France. The investigators hypothesize that the prevalence will be close to 10%, which is the prevalence that has been found in other European countries in previous studies.

Enrollment

1,000 estimated patients

Sex

All

Ages

13+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 13 years or older.
  • Resident in France and French-speaking.
  • Does not object to participating in the study, and, for minors, whose parents also do not object to their participation.

Exclusion criteria

  • Unable to understand and complete the questionnaire (e.g., non-French-speaking).

Trial design

1,000 participants in 1 patient group

Social media users
Description:
All French individuals aged 13 years or older who use social media
Treatment:
Other: Self-administered survey

Trial contacts and locations

1

Loading...

Central trial contact

Julia DE TERNAY, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems